Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112564403 | 11256440 | 3 | F | 20150627 | 20160920 | 20150709 | 20160924 | PER | US-GLAXOSMITHKLINE-US2015GSK097724 | GLAXOSMITHKLINE | 31.48 | YR | M | Y | 73.16000 | KG | 20160924 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112564403 | 11256440 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 400 MG, BID | U | 20241 | 400 | MG | TABLET | BID | |||||
| 112564403 | 11256440 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | U | 20241 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112564403 | 11256440 | 1 | Epilepsy |
| 112564403 | 11256440 | 2 | Seizure |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112564403 | 11256440 | Anticonvulsant drug level below therapeutic | |
| 112564403 | 11256440 | Drug dose omission | |
| 112564403 | 11256440 | Drug ineffective | |
| 112564403 | 11256440 | Emergency care examination |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |